BioCentury
ARTICLE | Clinical News

Lixivaptan regulatory update

July 30, 2012 7:00 AM UTC

FDA's Cardiovascular and Renal Drugs Advisory Committee will meet on Sept. 13 to discuss an NDA from Cornerstone for lixivaptan to treat symptomatic hypervolemic hyponatremia associated with heart fai...